Browse > Article

Differential Expression Patterns of Gangliosides in the Ischemic Cerebral Cortex Produced by Middle Cerebral Artery Occlusion  

Kwak, Dong Hoon (Department of Biological Science, College of Natural Sciences, Wonkwang University)
Kim, Sung Min (Department of Biological Science, College of Natural Sciences, Wonkwang University)
Lee, Dea Hoon (Department of Biological Science, College of Natural Sciences, Wonkwang University)
Kim, Ji Su (Department of Biological Science, College of Natural Sciences, Wonkwang University)
Kim, Sun Mi (Department of Biological Science, College of Natural Sciences, Wonkwang University)
Lee, Seo Ul (Department of Pharmacology, Wonkwang University School of Medicine)
Jung, Kyu Yong (Department of Pharmacology, Wonkwang University School of Medicine)
Seo, Byoung Boo (Department of Molecular and Experimental Medicine, The Scripps Research Institute)
Choo, Young Kug (Department of Biological Science, College of Natural Sciences, Wonkwang University)
Publication Information
Molecules and Cells / v.20, no.3, 2005 , pp. 354-360 More about this Journal
Abstract
Neuronal damage subsequent to transient cerebral ischemia is a multifactorial process involving several overlapping mechanisms. Gangliosides, sialic acid-conjugated glycosphingolipids, reduce the severity of acute brain damage in vitro. However their in vivo effects on the cerebral cortex damaged by ischemic infarct are unknown. To assess the possible protective role of gangliosides we examined their expression in the cerebral cortex damaged by ischemic infarct in the rat. Ischemia was induced by middle cerebral artery (MCA) occlusion, and the resulting damage was observed by staining with 2, 3, 5-triphenylterazolium chloride (TTC). High-performance thin-layer chromatography (HPTLC) showed that gangliosides GM3 and GM1 increased in the damaged cerebral cortex, and immunofluorescence microscopy also revealed a significant change in expression of GM1. In addition, in situ hybridization demonstrated an increase in the mRNA for ganglioside GM3 synthase. These results suggest that gangliosides GM1 and GM3 may be synthesized in vivo to protect the cerebral cortex from ischemic damage.
Keywords
Cerebral Cortex; Gangliosides; HPTLC; Ischemia; Monoclonal Antibody;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
Times Cited By Web Of Science : 9  (Related Records In Web of Science)
연도 인용수 순위
1 Komastsumoto, S., Greenberg, J. H., Hickey, W. F., and Reivich, M. (1988) Effect of ganglioside GM1 on neurologic function, electroencephalogram amplitude, and histology in chronic middle cerebral artery occlusion cats. Stroke 19, 1027-1035   DOI   ScienceOn
2 Mahadik, S. P. and Karpiak, S. E. (1988) Gnagliosides in treatment of neural injury and disease. Drug Dev. Res. 15, 337-360   DOI
3 Mahadik, S. P., Bharucha, V. A., Stadlin, A., Ortiz, A., and Karpiak, S. E. (1992) Loss and recovery of activities of and isozymes of $(Na^_+K^+$ -ATPase in cortical focal ischemia: GM1 ganglioside protects plasma membrane structure and function. J. Neurosci. Res. 32, 209-220   DOI   ScienceOn
4 Martinez, G., Carnazza, M. L., Campisi, A., Sorrenti, V., Di Giacomo, C., et al. (1998) Effect of glutathione depletors on post-ischemic reperfusion in rat brain. Neurochem. Res. 23, 961-968   DOI   ScienceOn
5 Ortiz, A., MacDonall, J. S., Wakade, C. G., and Karpiak, S. E. (1990) GM1 ganglioside reduces cognitive dysfunction after focal cortical ischemia. Pharmacol. Biochem. Behav. 37, 679-684   DOI   ScienceOn
6 Svennerholm, L. (1980) Gangliosides and synaptic transmission. In advances in experimental biology and medicine: structure and function of gangliosides. Adv. Exp. Med. Biol. 125, 533-544
7 Tananka, K., Dora, E., Ubranies, R., Greenberg, J. H., Toffano, G., et al. (1986) Effect of ganglioside GM1 on cerebral metabolism, microcirculation, recovery kinetics of ECoG and histology, during the recovery period following focal ischemia in cats. Stroke 17, 1170-1178   DOI   ScienceOn
8 Kurosawa, N., Yoshida, Y., Kojima, N., and Tsuji, S. (1997) Polysialic acid synthase (ST8Sia II/STX) mRNA expression in the developing mouse central nervous system. J. Neurochem. 69, 494-503   DOI   ScienceOn
9 Takamiya, K., Yamamoto, A., Furukawa, K., Yamashiro, S., Shin, M., et al. (1996) Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. Proc. Natl. Acad. Sci. USA 93, 10662-10667
10 Nojiri, H., Takaku, F., Terui, Y., Miura, Y., and Saito, M. (1986) Ganglioside GM3; an acidic membrane component that increase during macrophage-like cell differentiation can induce monocytic differentiation of human myeloid and monocytoid leulcemic cell lines H2-60 and U937. Proc. Natl. Acad. Sci. USA 83, 782-786
11 Djuricic, B. M., Pashen, W., Bosma, H. J., and Hossman, K. A. (1983) Biochemical changes during graded brain ischemia in gerbils. Part I. Global biochemical alterations. J. Neurol. Sci. 58, 25-36
12 Graus, F., Cordon-Cardo, C., Houghton, A. N., Melamed, M. R., and Old, I. J. (1984) Distribution of the ganglioside GD3 in human nervous system detected by R24 mouse monoclonal antibody. Brain Res. 324, 190-194   DOI   ScienceOn
13 Ferrari, G., Fabris, M., and Gorio, A. (1983) Gangliosides enhance neurite outgrowth in PC12 cells. Brain Res. 8, 215-221   DOI   ScienceOn
14 Fishman, P. H. and Brady, R. O. (1976) Biosynthesis and function of gangliosides. Science 194, 906-915   DOI
15 Liu, X. H., Kato, H., Araki, T., Itoyama, Y., Kato, K., et al. (1994) An immunohistochemical study of copper/zinc superoxide dismutase and manganese superoxide dismutase following focal cerebral ischemia in the rat. Brain Res. 644, 257-266   DOI   ScienceOn
16 Stojiljkovic, M., Blagojevic, T., Vukosavic, S., Zvezdina, N. D., Pekovic, S., et al. (1996) Ganglioside GM1 and GM3 in early human brain development: an immunocytochemical study. Int. J. Dev. Neurosci. 14, 35-44   DOI   ScienceOn
17 Kotani, M., Kawashima, I., Ozawa, H., Terashima, T., and Tai, T. (1993) Differential distribution of major gangliosides in rat central nervous system detected by specific monoclonal antibodies. Glycobiology 3, 137-146   DOI   ScienceOn
18 Kitamura, Y., Yanagisawa, D., Inden, M., Takata, K., Tsuchiya, D., et al. (2005) Recovery of focal brain ischemia-induced behavioral dysfunction by intracerebroventricular injection of microglia. J. Pharmacol. Sci. 97, 289-293   DOI   ScienceOn
19 Ogawa-Goto, K., Funamoto, N., Ohta, Y., Abe, T., and Nagashima, K. (1992) Myelin ganglioside of human peripheral nervous system: an enrichment of GM1 in the motor nerve myelin isolated from cauda equnia. J. Neurochem. 59, 1844-1849   DOI   ScienceOn
20 Siesjo, B. K. (1988) Calcium, ischemia and death of brain cells. Ann. N.Y. Acad. Sci. 522, 638-661   DOI
21 Choo, Y. K., Ichikawa, S., and Hirabayashi, Y. (2001) Developmental patterns of ceramide glucosyltransferase (GlcT-1) expression in the mouse: in situ hybridization using DIGlabeled RNA probes. Mol. Cells 11, 346-351
22 Sabel, B. A., Gottlieb, J., and Schneider, G. E. (1988) Exogenous GM1 gangliosides protect against retrograde degeneration following posterior neocortex lesions in developing hamsters. Brain Res. 459, 373-380   DOI   ScienceOn
23 Choi, D. W. (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634   DOI   ScienceOn
24 Hakomori, S. (1990) Bifunctional role of glycosphingolipids. Modulators for trans membrane signaling and mediators for cellular interaction. J. Biol. Chem. 265, 18713-18716
25 Lipartiti, M., Lazzaro, A., Zanoni, R., Mazzari, S., Toffano, G., et al. (1991) Monosialoganglioside GM1 reduces NMDA neurotoxicity in neonatal rat brain. Exp. Neurol. 113, 301-305   DOI   ScienceOn
26 Vaccarino, F., Guidotti, A., and Costa, E. (1987) Ganglioside inhibition of glutamate-mediated protein kinase C translocation in primary cultures of cerebellar neurons. Proc. Natl. Acad. Sci. USA 84, 8707-8711
27 Bharucha, V. A., Wakade, C. G., Mahadik, S. P., and Karpiak, S. E. (1991) GM1 ganglioside treatement reduces functional deficits associated with cortical focal ischemia. Exp. Neurol. 114, 136-139   DOI   ScienceOn
28 Hara, H., Huang, P. L., Panahian, N., Fishman, M. C., and Moskowitz, M. A. (1996) Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J. Cereb. Blood Flow. Metab. 16, 605-611
29 Hwang, I. K., Yoo, K. Y., Kim, D. S., Jung, J. Y., Kim, K. S., et al. (2004) Changes in parvalbumin immunoreactivity in the parietofrontal cortex after transient forebrain ischemia in the Mongolian gerbil. Mol. Cells 17, 304-308
30 Ledeen, R. W. and Yu, R. K. (1982) Gangliosides: structure, isolation, and analysis. Methods Enzymol. 83, 139-191   DOI
31 Iber, H., Zacharias, C., and Sandhoff, K. (1992) The c-series gangliosides GT3, GT2 and GP1c are formed in rat liver Golg. By the same set of glycosyltransferases that catalyse the biosynthesis of asialo-, a- and b-series gangliosides. Glycobiology 2, 137-142   DOI   ScienceOn
32 Choi, D. W. (1990) Methods for antagonizing glutamate neurotoxicity. Cerebrovasc. Brain Metab. Rev. 2, 105-147
33 Facci, L., Leon, A., Toffano, G., Sonnino, S., Ghidoni, R., et al. (1984) Promotion of neuritogenesis in mouse neuroblastoma cells by exogenous gangliosides. Relationship between the effect and cell association of ganglioside GM1. J. Neurochem. 42, 821?828
34 Ledden, R. W. (1984) Biology of gangliosides: neuritogenic and neuronotrophic properties. J. Neurosci. Res. 12, 147-159   DOI   ScienceOn
35 Karpiak, S. E. (1984) Exogenous gangliosides enhance recovery from CNS injury. Adv. Exp. Med. Bil. 174, 489-497
36 Willison, H. J. and Yuki, N. (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain 125, 2591-2625   DOI   ScienceOn
37 Kono, M., Takashima, S., Liu, H., Inoue, M., Kojima, N., et al. (1998) Molecular cloning and functional expression of a fifth-type alpha 2,3-sialytransferase (mST3Gal V: GM3 synthase). Biochem. Biophys. Res. Commun. 9, 170-175
38 Ji, M. Y., Lee, Y. C., Do, S. L., Nam, S. Y., Kim, H. M., et al. (2000) Developmental patterns of mST3GalV mRNA expression in the mouse: in situ hybridization using DIG-labeled RNA probes. Arch. Pharm. Res. 23, 525-530   과학기술학회마을   DOI   ScienceOn
39 Seren, M. S., Rubini, R., Lazzaro, A., Zanoni, R., Fiori, M. G., et al. (1990) Protective effects of a monosialoganglioside derivative following transitory forebrain ischemia in rats. Stroke 21, 1607-1612   DOI   ScienceOn
40 Ozawa, H., Kotani, M., Kawashima, I., and Tai, T. (1992) Generation of one set of monoclonal antibodies specific for bpathway ganglio-series gangliosides. Biochem. Biophys. Acta 1123, 184-190   DOI   ScienceOn
41 Apostolski, S. and Latov, N. (1993) Clinical syndromes associated with anti-GM1 antibodies. Semin. Neurol. 13, 264-268   DOI   ScienceOn
42 Hakomori, S., Yamamura, S., and Handa, A. K. (1998) Signal transduction through glyco (sphingo) lipid introduction and resent studies on glyco (sphingo) lipid-enriched microdomanins. Ann. N. Y. Acad. Sci. 845, 1-10   DOI
43 Facci, L., Skaper, S. D., Favaron, M., and Leon, A. (1988) A role for gangliosides in astroglial cell differentiation in vitro. J. Cell Biol. 106, 821-828   DOI   ScienceOn
44 Phillis, J. W. and O'Regan, M. H. (1995) GM1 ganglioside inhibits ischemia release of amino acid neurotransmitters from rat cortex. NeuroReport 6, 2010-2012   DOI   ScienceOn
45 Stull, N. D., Schneider, J. S., and Iacovitti, L. (1994) GM1 ganglioside partially rescues cultures dopaminergic neurons from MPP+-induced damage: dependence on initial damage and time of treatment. Brain Res. 640, 308-315   DOI   ScienceOn